Itherx Pharmaceuticals, Inc.
Records under this name other than patents Itherx Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Itherx Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,919,617 | Cytokine inhibitors Formerly held Lapsed on the fee record Ended Apr 5, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 5, 2023 | From the USPTO record |
| US 7,897,599 | Cytokine inhibitors Formerly held Lapsed on the fee record Ended Mar 1, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 1, 2019 | From the USPTO record |
| US 7,749,999 | Alpha-ketoamides and derivatives thereof Formerly held Lapsed on the fee record Ended Jul 6, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 6, 2018 | From the USPTO record |
| US 7,396,936 | Modulators of calcitonin and amylin receptor activity Lapsed on the fee record Ended Jul 8, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jul 8, 2012 | From the USPTO record |